Literature DB >> 22136824

Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years.

Melanie Goldfarb1, Stephen Gondek, George L Irvin, John I Lew.   

Abstract

BACKGROUND: The long-term significance of normocalcemic parathormone elevation (NPE) after successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear.
METHOD: Of 239 consecutive patients who underwent targeted parathyroidectomy with intraoperative parathormone monitoring, 96 were followed for ≥ 10 years. NPE was defined as a normal serum calcium level and parathormone (PTH) above the normal reference range ≥ 6 months after successful parathyroidectomy. Recurrence was defined as elevated serum calcium and PTH levels ≥ 6 months after parathyroidectomy. Risk factors for NPE, patterns of postoperative PTH variation, and 10-year outcomes were analyzed.
RESULTS: Of 96 patients followed ≥ 10 years, 42 had postoperative NPE. Only male gender (P = .008) was a risk factor for NPE, and NPE did not predict recurrence. Three patterns of postoperative NPE were identified in patients with ≥ 3 PTH measurements over this 10-year period. Group 1 (n = 11): 1 to 2 consecutive PTH elevations; none recurred, and most were explained by physiologic variation. Group 2 (n = 23): multiple PTH fluctuations; 3 recurred, and almost all had physiologic variations. Group 3 (n = 4): PTH always elevated; 2 recurred.
CONCLUSION: Postoperative NPE may be a dynamic, reversible, and transient clinical entity that does not predict recurrence. Nevertheless, patients with postoperative NPE should be monitored and an attempt made to correct any obvious potential causes of PTH elevation.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136824     DOI: 10.1016/j.surg.2011.09.017

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  What Should We Tell Our Patients? Lifetime Guarantee or is it 5- to 10-year Warranty on a Parathyroidectomy for Primary Hyperparathyroidism?

Authors:  Janice L Pasieka
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 2.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

3.  Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.

Authors:  Marie Caldwell; Jeff Laux; Marshall Clark; Lawrence Kim; Janet Rubin
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 4.  Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.

Authors:  Joaquín Gómez-Ramírez; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2017-08-19       Impact factor: 3.445

5.  How should we define cure after parathyroidectomy for normocalcemic primary hyperparathyroidism? A retrospective cohort study.

Authors:  Oscar Cano-Valderrama; Santiago Ochagavía; Concepción Sanabria; Cristina Familiar; Jesús Díaz; Sara Picazo; Patricia Sáez-Carlin; Antonio J Torres
Journal:  Updates Surg       Date:  2021-06-07

6.  Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

7.  Significance of rebounding parathyroid hormone levels during parathyroidectomy.

Authors:  David F Schneider; Kristin A Ojomo; Haggi Mazeh; Sarah C Oltmann; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2013-05-03       Impact factor: 2.192

8.  SURGERY OUTCOMES IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM AND IMPACT OF INTRA-OPERATIVE PTH MEASUREMENT.

Authors:  A B Amza; V Muntean; G Dindelegan; C Ciuce; C E Georgescu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

9.  A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients.

Authors:  Shaobo Cao; Ya Hu; Yiming Zhao; Zhe Su; Zhiyan Xu; Xiang Gao; Quan Liao; Yupei Zhao
Journal:  Oncotarget       Date:  2017-08-24

10.  Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Wenjing Ni; Yue Yuan; Xiaoqiu Chu; Guofang Chen; Xue Han; Jie Li; Xinping Wu; Jianhua Wang; Chao Liu; Shuhang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.